Stock listing
Intellia Therapeutics, Inc. (NTLA) Stock Price, News, Filings & Events
Selected listing: NTLA · NASDAQ · USD · US
This page tracks Intellia Therapeutics, Inc.'s NTLA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NTLA:NASDAQ. NTLA:NASDAQ is the selected stock listing for investors researching Intellia Therapeutics, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to NTLA:NASDAQ. Intellia Therapeutics, Inc. is a public biotechnology company listed under the ticker NTLA on the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2. 19 billion.
- Ticker
- NTLA:NASDAQ
- Asset type
- Stock
- Market cap
- $2.33B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Intellia Therapeutics, Inc. NTLA:NASDAQ stock context
This page tracks Intellia Therapeutics, Inc.'s NTLA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NTLA:NASDAQ. NTLA:NASDAQ is the selected stock listing for investors researching Intellia Therapeutics, Inc.; the company-level investor brief is shared across the issuer while this page keeps ticker, exchange, currency, and canonical URL signals specific to NTLA:NASDAQ. Intellia Therapeutics, Inc. is a public biotechnology company listed under the ticker NTLA on the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2. 19 billion.
Research Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for NTLA:NASDAQ.
Intellia Therapeutics, Inc. company profile
View the public company page for Intellia Therapeutics, Inc. on 6ix.
Intellia Therapeutics, Inc. news
Read company news and market updates connected to Intellia Therapeutics, Inc..
Intellia Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Intellia Therapeutics, Inc..
Alternate listings
38I:GETTEX
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
A2AG6H:LSX
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
NTLA:BOATS
US · USD
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:TRADEGATE
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
A2AG6H:LS
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:HAM
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
0JBU:LSE
GB · USD
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:FWB
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:SWB
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:BX
CH · CHF
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:DUS
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:MUN
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.